Table IV.
Side effects recorded during treatment in the three groups
|
Group A
( n = 30) |
Group B
(n =30) |
Group C
(n = 30) |
P1 | P2 | P3 | |
|---|---|---|---|---|---|---|
| Headache | 5 | 15 | 18 | < 0.001* | < 0.001* | 0.78 |
| Nausea and vomiting | 3 | 5 | 5 | 0.34 | 1 | 1 |
| Dizziness | 7 | 10 | 12 | 0.56 | 0.01* | 0.87 |
| Syncope | 0 | 0 | 2 | 1 | 0.003* | 0.003* |
| Fatigue | 9 | 8 | 7 | 0.93 | 0.87 | 0.84 |
| Nervousness | 1 | 1 | 1 | 1 | 1 | 1 |
| Insomnia | 4 | 4 | 5 | 1 | 0.76 | 0.76 |
| Flushing | 2 | 8 | 10 | < 0.001* | < 0.001* | 0.75 |
| Palpitation | 3 | 11 | 12 | < 0.001* | < 0.001* | 0.92 |
| Hypotension | 9 | 10 | 10 | 0.88 | 0.88 | 1 |
| Hypersensitivity | 0 | 0 | 0 | 1 | 1 | 1 |
| OHSS | 2 | 1 | 2 | 0.54 | 1 | 0.54 |
| Breast discomfort | 7 | 7 | 8 | 1 | 0.78 | 0.78 |
| Ovarian cysts | 8 | 4 | 4 | 0.01* | 0.01* | 1 |
| Transient blurring of vision | 2 | 2 | 2 | 1 | 1 | 1 |
Data are presented as number of cases. P1: p value between group A and group B. P2: p value between group A and group C. P3: p value between group B and group C.
*
one way ANOVA test, p-value <0.05 considered significant.